Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

A human pluripotent stem cell surface N-glycoproteome resource reveals markers, extracellular epitopes, and drug targets.

Boheler KR, Bhattacharya S, Kropp EM, Chuppa S, Riordon DR, Bausch-Fluck D, Burridge PW, Wu JC, Wersto RP, Chan GC, Rao S, Wollscheid B, Gundry RL.

Stem Cell Reports. 2014 Jun 6;3(1):185-203. doi: 10.1016/j.stemcr.2014.05.002.

2.

Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.

Abraham S, Sheridan SD, Miller B, Rao RR.

Biotechnol Prog. 2010 Jul-Aug;26(4):1126-34. doi: 10.1002/btpr.412.

PMID:
20730767
3.

Concise Review: Cell Surface N-Linked Glycoproteins as Potential Stem Cell Markers and Drug Targets.

Boheler KR, Gundry RL.

Stem Cells Transl Med. 2016 Jul 28. pii: sctm.2016-0109. [Epub ahead of print]

PMID:
27471308
4.

An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells.

Tang C, Lee AS, Volkmer JP, Sahoo D, Nag D, Mosley AR, Inlay MA, Ardehali R, Chavez SL, Pera RR, Behr B, Wu JC, Weissman IL, Drukker M.

Nat Biotechnol. 2011 Aug 14;29(9):829-34. doi: 10.1038/nbt.1947.

5.

Immunocytochemical analysis of human pluripotent stem cells using a self-made cytospin apparatus.

Pascual EY, Riggs MJ, Rao RR.

J Vis Exp. 2010 Apr 9;(38). pii: 1944. doi: 10.3791/1944.

6.

The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells.

Munoz J, Low TY, Kok YJ, Chin A, Frese CK, Ding V, Choo A, Heck AJ.

Mol Syst Biol. 2011 Nov 22;7:550. doi: 10.1038/msb.2011.84.

7.

In vitro culture and directed osteogenic differentiation of human pluripotent stem cells on peptides-decorated two-dimensional microenvironment.

Wang M, Deng Y, Zhou P, Luo Z, Li Q, Xie B, Zhang X, Chen T, Pei D, Tang Z, Wei S.

ACS Appl Mater Interfaces. 2015 Mar 4;7(8):4560-72. doi: 10.1021/acsami.5b00188.

PMID:
25671246
8.

Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis.

Wang YC, Nakagawa M, Garitaonandia I, Slavin I, Altun G, Lacharite RM, Nazor KL, Tran HT, Lynch CL, Leonardo TR, Liu Y, Peterson SE, Laurent LC, Yamanaka S, Loring JF.

Cell Res. 2011 Nov;21(11):1551-63. doi: 10.1038/cr.2011.148.

9.

Sialyl-lactotetra, a novel cell surface marker of undifferentiated human pluripotent stem cells.

Barone A, Säljö K, Benktander J, Blomqvist M, Månsson JE, Johansson BR, Mölne J, Aspegren A, Björquist P, Breimer ME, Teneberg S.

J Biol Chem. 2014 Jul 4;289(27):18846-59. doi: 10.1074/jbc.M114.568832.

10.

Design of a Vitronectin-Based Recombinant Protein as a Defined Substrate for Differentiation of Human Pluripotent Stem Cells into Hepatocyte-Like Cells.

Nagaoka M, Kobayashi M, Kawai C, Mallanna SK, Duncan SA.

PLoS One. 2015 Aug 26;10(8):e0136350. doi: 10.1371/journal.pone.0136350.

11.

An orthogonal comparison of the proteome of human embryonic stem cells with that of human induced pluripotent stem cells of different genetic background.

Faradonbeh MZ, Gharechahi J, Mollamohammadi S, Pakzad M, Taei A, Rassouli H, Baharvand H, Salekdeh GH.

Mol Biosyst. 2012 Jun;8(6):1833-40. doi: 10.1039/c2mb25018g.

PMID:
22543856
12.

Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.

Meng G, Liu S, Rancourt DE.

Stem Cells Dev. 2012 Jul 20;21(11):2036-48. doi: 10.1089/scd.2011.0489.

PMID:
22149941
13.

Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.

Lee MO, Moon SH, Jeong HC, Yi JY, Lee TH, Shim SH, Rhee YH, Lee SH, Oh SJ, Lee MY, Han MJ, Cho YS, Chung HM, Kim KS, Cha HJ.

Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):E3281-90. doi: 10.1073/pnas.1303669110.

14.

High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry.

Bhattacharya S, Burridge PW, Kropp EM, Chuppa SL, Kwok WM, Wu JC, Boheler KR, Gundry RL.

J Vis Exp. 2014 Sep 23;(91):52010. doi: 10.3791/52010.

15.

New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells.

O'Brien CM, Chy HS, Zhou Q, Blumenfeld S, Lambshead JW, Liu X, Kie J, Capaldo BD, Chung TL, Adams TE, Phan T, Bentley JD, McKinstry WJ, Oliva K, McMurrick PJ, Wang YC, Rossello FJ, Lindeman GJ, Chen D, Jarde T, Clark AT, Abud HE, Visvader JE, Nefzger CM, Polo JM, Loring JF, Laslett AL.

Stem Cells. 2016 Dec 23. doi: 10.1002/stem.2558. [Epub ahead of print]

PMID:
28009074
16.

Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes.

Takenaka C, Miyajima H, Yoda Y, Imazato H, Yamamoto T, Gomi S, Ohshima Y, Kagawa K, Sasaki T, Kawamata S.

PLoS One. 2015 Jun 26;10(6):e0129855. doi: 10.1371/journal.pone.0129855.

17.

Concise Review: Cell Surface N-Linked Glycoproteins as Potential Stem Cell Markers and Drug Targets.

Boheler KR, Gundry RL.

Stem Cells Transl Med. 2017 Jan;6(1):131-138. doi: 10.5966/sctm.2016-0109.

PMID:
28170199
18.

Gene targeting in human pluripotent stem cells.

Liu Y, Rao M.

Methods Mol Biol. 2011;767:355-67. doi: 10.1007/978-1-61779-201-4_26.

PMID:
21822888
19.

Defining the nature of human pluripotent stem cell progeny.

Patterson M, Chan DN, Ha I, Case D, Cui Y, Van Handel B, Mikkola HK, Lowry WE.

Cell Res. 2012 Jan;22(1):178-93. doi: 10.1038/cr.2011.133.

20.

Integrated transcriptome and binding sites analysis implicates E2F in the regulation of self-renewal in human pluripotent stem cells.

Yeo HC, Beh TT, Quek JJ, Koh G, Chan KK, Lee DY.

PLoS One. 2011;6(11):e27231. doi: 10.1371/journal.pone.0027231.

Items per page

Supplemental Content

Support Center